Feng T, Zhao X, Gu P, Yang W, Wang C, Guo Q, et al
56 LiuC
DrWell is here to make that easy, clinically supported, and profitable
The Canadian Drug Agency assessed Wegovy's cost-effectiveness in July 2025 and recommended a price reduction, and December 2025 negotiations between the pan-Canadian Pharmaceutical Alliance and Novo Nordisk concluded without agreement [Source: ogaei.ca/blog/wegovy-cost-in-canada/]
In monotherapy trials with semaglutide oral tablets for T2DM, severe hypoglycemia (requiring the assistance of another person) was reported in 1% of patients receiving the 7 mg tablets and 0% of patients receiving the 14 mg tablets or placebo
Superguts Marc Washington is Meeting The Moment: Were Very Much Here for the Ozempic Era Marc Washington, CEO of superfood brand Supergut, speaks to Green Queen about riding the Ozempic wave, the importance of prebiotic fibre, boosting GLP-1, and formulating plant-based products